Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Acquisition
Sort By
Newest First
1 / 1
1 / 1
Acquisition
Ampersand Capital Partners Aquired Nektar Therapeutics' PEG Reagent Manufacturing Business, Launching Newly Branded Gannet BioChem
Ampersand Capital Partners
PR-12-24-NI-121
Dec 02, 2024
Axonics
Boston Scientific Closes Acquisition of Axonics, Inc.
Boston Scientific
PR-11-24-NI-105
Nov 15, 2024
Vantage Nutrition LLC Acquires ComboCap Inc
Vantage Solutions
PR-M03-23-07
Mar 27, 2023
Acquisition and Rebranding
Dr. Glenn Haifer and Ampersand Capital Partners Acquire Australian Biologics CDMO Luina Bio, Rebranding as AcuraBio
AcuraBio
PR-M09-22-01
Sep 07, 2022
M&A
Novo Holdings Portfolio Company ReViral to be Acquired by Pfizer
Novo Holdings A/S
PR-M04-22-05
Apr 07, 2022
M&A
TriRx Completes Acquisition of Elanco Manufacturing Facility in Speke, United Kingdom
TriRx Pharmaceutical Services
PR-M02-22-06
Feb 08, 2022
Facility Acquisition
Fujifilm Expands its Advanced Therapies CDMO Business with the Acquisition of a Dedicated Cell Therapy Manufacturing Facility from Atara Biotherapeutics, Inc.
Fujifilm Diosynth Biotechnologies
PR-M01-22-18
Jan 26, 2022
New Facility
TriRx Hosted State and Community Leaders to Celebrate Acquisition of Shawnee, Kansas Facility
TriRx Pharmaceutical Services
PR-M07-21-013
Aug 11, 2021
Acquisition
TriRx Completes Acquisition of Elanco Animal Health Facility in Shawnee, Kansas
TriRx Pharmaceutical Services
PR-M08-21-01
Aug 02, 2021
Facility Acquisition
TriRx Enters Agreement for the Acquisition of Elanco Animal Health Facilities in Shawnee, Kansas and Speke, United Kingdom
TriRx Pharmaceutical Services
PR-M06-21-019
Jun 15, 2021
Acquisition
Grifols Reinforces its Innovation Strategy After Completing the Acquisition of GigaGen to Boost a Novel Method to Generate a Wide Range of Immunoglobulins
Grifols
PR-M11-20-045
Mar 09, 2021
WuXi AppTec Completes Acquisition of OXGENE to Further Strengthen Cell and Gene Therapy Service Offerings for Global Customers
WuXi AppTec
PR-M11-20-040
Mar 02, 2021
Acquisition
Thermo Fisher Scientific Acquires Viral Vector Manufacturing Business from Novasep
Thermo Fisher Scientific
PR-M11-20-035
Jan 15, 2021
M&A
AbCellera Expands Technology Stack with Acquisition of Trianni for $90 Million
AbCellera Biologics Inc.
PR-M11-20-018
Nov 19, 2020